Topic: Sickle Cell

1 chapters across the catalog

Dr. Fleming compares the current vaccination strategy to the overuse of antibiotics, which promotes the survival of resistant strains. He argues that by targeting only one spike protein, the vaccines are "designed to fail" against variants like Delta and Lambda. He explains how small mutational changes, similar to the single base change in sickle cell anemia, can provide a survival advantage to new variants.